Live and On-Demand Events

European Regulatory View to the End of the Year

September 15, 2026 | 10:00 am – 11:00 am

Kari Oakes, Corey Jaseph, MS, RAC, Sebastian Godoy, MPH, Faraz Kermani

Even following the slow summer months, there’s a bevy of moving policy pieces impacting life sciences companies operating in the EU and for regulatory professionals to catch up on. In this back-to-school webinar, AgencyIQ experts will provide a status check on key legislation affecting regulatory stakeholders, including the Pharma Package, Critical Medicines Act and Biotech I. We’ll also cover key developments in the proposed adjustments to the medical device regulation and in vitro diagnostic regulations.

Our experts will provide a view of the critical deliverables and deadlines we’re expecting from European regulators through the end of Q3 and a forecast into Q4 – and as always, we’ll be taking your questions!

Q4 Preview: User Fees, Leadership and the Race to the End of the Year

September 1, 2026 | AVAILABLE ON-DEMAND

Alexander Gaffney, MS, RAC, Ned Pagliarulo, Amanda Conti, Laura DiAngelo, MPH

After a busy summer, we’re gearing up for the race to the end of the year in life sciences regulatory policy. We anticipate another busy season, with leadership changes coming for the FDA, the finalization of the medical product user fee agreements for the upcoming reauthorizations, a new funding cycle, and a midterm election expected to have widespread impact on the way that lawmakers work on regulatory issues. Amidst all those moving pieces, the FDA’s regulatory agendas show an ambitious policymaking cadence through the end of the year.

Join AgencyIQ’s experts for a lively and informative webinar that will cover recent regulatory, policy and political developments, and what we expect lies ahead for the regulated medical product industry.

FDA’s Food Blitz: GRAS, UPFs, and What’s Next

August 25, 2026 | AVAILABLE ON-DEMAND

Jared Rothstein, Scarlett Salem, MS, MPH, John Herlihy, PhD

The pace of food policymaking at the FDA continues to intensify, with a flurry of significant announcements and policy developments this month.

Join AgencyIQ’s regulatory experts for a lively and informative webinar unpacking the FDA’s proposed GRAS rule, its new ultra-processed foods whitepaper, and other recent rules, policies, and guidance shaping the regulatory landscape.

We’ll break down what the FDA has announced, what it means for the food sector, and what stakeholders should be watching next. Plus, we’ll answer your questions live.

FDA’s Busy Summer (So Far)

August 11, 2026 | AVAILABLE ON-DEMAND

Laura DiAngelo, MPH, Amanda Conti and Ned Pagliarulo

No summertime slowdown here – The FDA has been exceptionally busy in the last month, with the release of important new regulatory proposals, major guidance documents, new actions on longstanding priorities, and ongoing leadership questions. On Capitol Hill, lawmakers have introduced – and are advancing – legislative proposals that could shape the agency for years to come as the annual appropriations process proceeds and as lawmakers prepare for the upcoming user fee reauthorization process.

We know our subscribers have questions, and AgencyIQ is here to provide answers.
Join AgencyIQ by POLITICO’s Life Sciences team on Tuesday, August 11, at 12:00 pm ET for a lively, informative, and actionable webinar exploring the FDA’s latest regulatory changes affecting the pharmaceuticals, biopharmaceutical, medical device, and diagnostics industries. We’ll explore the latest regulations, guidances, major policy developments and policy agendas. Plus, our experts will be on hand to answer your questions live.

The 2026 Unified Agenda: What’s Next for FDA, USDA, and EPA

July 21, 2026 | AVAILABLE ON-DEMAND

Jared Rothstein, John Herlihy, PhD, Julia John, MS

The second half of 2026 is shaping up to be a pivotal time for the food and chemicals sectors. After a slow start to the year, the Trump administration has accelerated its policymaking agenda, with a wave of significant regulations, guidance documents, and policy initiatives on the horizon. The release of the federal government’s 2026 Unified Agenda provides the clearest picture yet of what’s ahead.

In this lively and informative webinar, AgencyIQ’s regulatory experts will unpack the Unified Agenda and discuss what actions FDA, USDA, and EPA still have in store for this year. We’ll highlight the latest signals, trends, and forecasted actions and spotlight what regulatory professionals can expect over the coming months. Plus, we’ll be answering your questions live.

FDA Regulatory Update: Unpacking FDA’s newest policy proposals

July 8, 2026 | AVAILABLE ON-DEMAND

Laura DiAngelo, MPH, Amanda Conti, Ned Pagliarulo

The FDA has been busy in June, releasing a series of consequential documents that could reshape its research and development policies in important ways. Join AgencyIQ’s experts for a lively and informative webinar that will cover “Operation Trialblazer” as well as much-anticipated guidance. We’ll also discuss what we’re watching next and what we expect still lies ahead for the regulated medical product industry.

Food Regulatory Update: State Activity in 2026

June 16, 2026 | AVAILABLE ON-DEMAND

Jared Rothstein, Scarlett Salem, MS, MPH, John Herlihy, PhD

We’re midway through 2026 and already it’s been a banner year for state policymaking in the food sector. States are advancing an increasingly wide range of food-related policies, shifting aspects of food oversight and regulation away from federal agencies. For regulatory professionals, navigating this growing patchwork of state requirements is becoming increasingly complex.

Join AgencyIQ’s regulatory experts for a fast-paced, actionable webinar unpacking the latest wave of state food policy activity so far this year.

FDA Update: Leadership Turnover and What it Means for FDA Policy and Priorities

June 2, 2026 | AVAILABLE ON-DEMAND

Laura DiAngelo, MPH, Ned Pagliarulo

In our last webinar, we provided a one-year check in on Commissioner MARTIN MAKARY. Now, the Commissioner and several of his top deputies have left or been re-shuffled within the agency – leaving several high-profile and high-priority initiatives in limbo following the leadership shakeup. Join AgencyIQ’s experts for a lively and informative webinar to cover the significant changes at the agency, what’s changed, what we are still waiting to hear, key deadlines and what we expect is coming next for the regulated medical product industry.

Preparing for a Wave of New European Regulatory and Legislative Reforms Affecting Life Sciences Companies

May 19, 2026 | AVAILABLE ON-DEMAND

Sebastian Godoy, MPH, Corey Jaseph, MS, RAC, Kari Oakes

Life sciences firms operating in the Europe can expect an implementation wave for long-discussed policy changes in the second half of the year: The EMA is talking about its new governance structure, there’s new movement on the MDR and IVDR, and the U.K. has rolled out new guidance on its clinical trial reforms. At the same time, Biotech Act I and the digital omnibus are proceeding through the complex EU legislative process.

Join AgencyIQ for our next webinar on Tuesday, May 19 at 10:00am ET, as we break down the EU landscape, spotlighting key regulatory updates and flagging important deadlines for life sciences stakeholders.

FDA’s Food Budget, Priorities, and Upcoming Workplans

April 28, 2026 | AVAILABLE ON-DEMAND

Alexander Gaffney, MS, RAC, Scarlett Salem, MPH, MS, Jared Rothstein, John Herlihy, PhD

It’s been one year since Commissioner Martin Makary took the helm at the FDA, and the agency continues to advance significant changes across its food regulatory agenda. With the recent release of the FDA’s FY 2027 budget, the agency has also provided new insight into its priorities, proposed resources, and planned work for 2026 and beyond.

Join AgencyIQ’s regulatory experts on Tuesday, April 28 at 12:00 pm ET for a timely, informative, and actionable webinar covering the latest FDA food policy developments

FDA Forecast: The 2026-2027 Season

April 22, 2026 | AVAILABLE ON-DEMAND

Alexander Gaffney, MS, RAC, Laura DiAngelo, MPH, Amanda Conti, Ned Pagliarulo

With one year down under Commissioner Martin Makary’s tenure helming the FDA, the administration has sought to make sweeping changes to the agency’s policies and systems. The White House’s FY 2027 budget, and Makary’s plans for the upcoming year, preview what’s still on the horizon.

Join AgencyIQ’s experts for a lively and informative webinar to cover the significant changes over the last year at the agency, what’s changed, what we are still waiting on, and what we expect is coming next for the regulated medical product industry.

Food Policy in Motion: New Regulations and Signals, and What It All Means

March 24, 2026 | AVAILABLE ON-DEMAND

Jared Rothstein, Scarlett Salem, MPH, MS, Alexander Gaffney, MS, RAC

The food policy landscape has remained exceptionally active over the past month, with new developments across both the regulatory and legislative fronts. We know our subscribers have questions, and AgencyIQ is here to provide answers.

Join AgencyIQ by POLITICO’s Food team on Tuesday, March 24 at 12:00 pm ET, for a lively, informative, and actionable webinar unpacking the latest policy activity at the FDA and USDA, emerging signals from agency leadership, and key legislative developments in Congress that could shape food regulation in the months ahead. Plus, our experts will answer your questions live.

FDA Update: Making Sense of FDA’s Productive (and Tumultuous) Last Few Weeks

March 17, 2026 | AVAILABLE ON-DEMAND

Alexander Gaffney, MS, RAC, Laura DiAngelo, MPH, Amanda Conti, Ned Pagliarulo

The FDA has been exceptionally busy in the last month, with the release of important new regulations, major guidance documents, notable approvals, scandal surrounding rejections, and major staff departures announced.

We know our subscribers have questions, and AgencyIQ is here to provide answers.

Join AgencyIQ by POLITICO’s Life Sciences team on Tuesday, March 17, at 12:00 pm ET for a lively, informative, and actionable webinar exploring the FDA’s latest regulatory changes affecting the pharmaceuticals, biopharmaceutical, medical device, and diagnostics industries. We’ll explore the latest regulations, guidances, major policy developments and policy agendas. Plus, our experts will be on hand to answer your questions live.

European Life Sciences Regulatory Forecast

March 11, 2026 | AVAILABLE ON-DEMAND

Corey Jaseph, Sebastian Godoy, David Breyer, Kari Oakes

For life sciences firms operating in the EU, it’s been a busy 2026 – with more to come this year. AgencyIQ will walk regulatory professionals through what they need to know as European officials move to make some significant changes, including new movement on the Medical Device Regulations and In Vitro Diagnostic Regulations, various legislative bids to update medicines systems, and what guidance we’re anticipating this year. Join us for a lively, fast-paced webinar, where will be answering your questions about what’s next for life sciences regulation in 2026.

FDA Regulatory Update: Unpacking FDA’s Early Policy Actions in 2026

February 24, 2026 | AVAILABLE ON-DEMAND

Jared Rothstein, Scarlett Salem, MPH, MS, Alexander Gaffney, MS, RAC

The FDA is wasting no time in 2026. In just the first weeks of the year, the agency has rolled out policy announcements with significant implications for food labeling, safety, and ingredient regulation—offering early clues about its priorities for the year ahead.

AgencyIQ’s food research team will decode these developments, highlighting what’s new, what’s coming next, and what regulated companies should be watching now. The webinar will cover recently issued and emerging regulations and guidance, assess broader policy trends shaping the FDA’s 2026 agenda, and include a live Q&A with our experts.

FDA Update: New Authority, Guidance and Pending Reforms Affecting the Life Sciences Industries

February 18, 2026 | AVAILABLE ON-DEMAND

Alexander Gaffney, MS, RAC, Laura DiAngelo, MPH, Amanda Conti

The FDA is off to a fast start this year with major policy announcements, a suite of new authorities given to it by Congress under the latest appropriations bill, new programs, and signs that it is getting ready to undertake a series of significant policy reforms related to drugs and medical devices.

Join AgencyIQ by POLITICO’s Life Sciences team on Wednesday, February 18 at 12:00 pm ET for a lively, informative, and actionable webinar exploring the FDA’s latest regulatory changes affecting the pharmaceuticals, biopharmaceutical, medical device, and diagnostics industries. We’ll explore the latest regulations, guidances, major policy developments and policy agendas. Plus, our experts will be on hand to answer your questions live.

AgencyIQ attending RAPS Convergence 2025

October 7, 2025 | INDUSTRY EVENT

Alexander Gaffney, Laura DiAngelo, Amanda Conti, Sebastian Godoy, Joshua Sztorc, Casey Miles, Helena Tewolde

The AgencyIQ team will be at RAPS Convergence 2025 at the David L. Lawrence Convention Center in Pittsburgh, PA — the largest annual gathering of global regulatory affairs professionals. Join us at  booth #909 to connect with our experts, explore the AgencyIQ platform, and see how we help life sciences organizations stay ahead of regulatory change.